First-Line HER2+ Metastatic Breast Cancer: DESTINY-Breast09 & the Future of Care - Dr. Irene Kang & Dr. Aditya Bardia episode artwork

EPISODE · Jan 6, 2026 · 31 MIN

First-Line HER2+ Metastatic Breast Cancer: DESTINY-Breast09 & the Future of Care - Dr. Irene Kang & Dr. Aditya Bardia

from Community Health Media · host Community Health Media

Recorded live, this in-depth conversation features Dr. Irene Kang and Dr. Aditya Bardia breaking down the DESTINY-Breast09 data and what it means for first-line treatment of metastatic HER2-positive breast cancer.From challenging the long-standing THP standard to unpacking unprecedented progression-free survival, higher complete response rates, and CNS activity with T-DXd, this discussion explores how and why first-line decision-making is evolving. The panel also dives into patient selection, toxicity management, ILD monitoring, dose optimization, induction vs maintenance strategies, and how to frame these advances in real-world patient conversations.A must-watch for clinicians navigating the next era of HER2-positive metastatic breast cancer care.#HER2Positive #BreastCancer #DESTINYBreast09 #TDXd #Oncology #MedicalOncology #BreastOncology #CancerResearch #ClinicalTrials #PrecisionOncology #ESMO #ASCO #CommunityHealthMedia–Thanks for watching!Our podcasts are also available on: • Spotify - https://spotf.fi/chm-podcast • Amazon Music - https://amazn.so/chm-podcast • Apple Podcast - https://podcasts.apple.com/us/podcast/community-health-media/id1837428248 • Castbox - https://castbox.fm/vh/6735434 • Goodpods - https://goodpods.com/profile/chm-111066 • iHeartRadio - https://iheart.com/podcast/291542082 • Pocket Casts - https://pca.st/3ncdh11o–Community Health Media (CHM) is your full service healthcare communications partner, combining our production expertise with targeted multi-channel campaigns. We connect companies and healthcare brands with key opinion leaders, patients, and consumers through compelling content and live experiences.We’re an integrated marketing company that produces world-class content and curated peer to peer live experiences.We specialize in: • Peer to peer interviews, panels & round-tables • Curated live events & conferences • Professional in-depth content & research updates • Interactive learning modules & webinars • Live & on-demand webcasts & podcastsLearn more about us here - https://communityhealth.media

Episode metadata supplied by the publisher feed · Published Jan 6, 2026

Embed this episode

Ready to play

First-Line HER2+ Metastatic Breast Cancer: DESTINY-Breast09 & the Future of Care - Dr. Irene Kang & Dr. Aditya Bardia

0:00 31:05

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Community Health Media?

This episode is 31 minutes long.

When was this Community Health Media episode published?

This episode was published on January 6, 2026.

Can I download this Community Health Media episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!